Diabetes And Hepatic Dysfunction: Exploring the Complex Connection in Metabolic Health

Chronic liver diseases and diabetes are sized health challenges worldwide; the two conditions demonstrate a multifaceted and reciprocal association that is cropping up more frequently in clinical practice and scientific investigations. More importantly, liver as an organ, has fundamental function in control of glycometabolic homeostasis and liver disease can certainly also exacerbate insulin resistances which in turn leads to the development of diabetes. On the other hand, diabetes and most especially type 2 diabetes are risk factors for NAFLD, which is the most prevalent liver disease in metabolic syndromes. NAFLD may further progress to more aggressive liver diseases, NASH, cirrhosis and HCC. Possible molecular level linkages include interference with lipid metabolism, inflammation and oxidative stress as well as changes in the overall digestive tract bacterial flora. Moreover, both conditions have risk factors, including obesity, dyslipidemia, and hypertension, which contribute to factors that interact between them. Therefore, this review will attempt to provide an overview of the literature concerning hepatic injury and diabetes, the pathophysiologic connections, diagnostic concerns, and therapies for dealing with these complicated conditions. It is incumbent upon health educators, clinicians, and policymakers to comprehensively understand this relationship so that innovative strategies based on this positive association will facilitate early adoption of successful diagnosis and prevention and treatment measures of both liver diseases and diabetes in which the burden impact of both diseases overlap immensely.